secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-04-03T23:59:59+00:00
Accession:  0001193125-26-142089
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics implements 1-for-20 reverse stock split effective March 30, 2026
-------------------------------------------------------------------------------

- Reverse split ratio of 1:20; every 20 shares converted to 1 share.
- No fractional shares issued; any fractional interests rounded up to the nearest whole share.
- Par value unchanged at $0.00001; authorized shares unchanged.
- CUSIP changed to 31573L204; trading symbol remains 'FBLG'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526142089/0001193125-26-142089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526142089/fblg-20260330.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-142089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer